OTCMKTS:CHLLF China Literature (CHLLF) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free CHLLF Stock Alerts $3.25 0.00 (0.00%) (As of 05/9/2024 ET) Add Compare Share Share Today's Range$3.25▼$3.2550-Day Range$3.25▼$3.2952-Week Range$3.25▼$3.25VolumeN/AAverage Volume244 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get China Literature alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About China Literature Stock (OTCMKTS:CHLLF)China Literature Limited, an investment holding company, operates an online literature platform in the People's Republic of China. The company promotes intellectual properties primarily through its online literature platforms, such as QQ Reading and Qidian; and New Classics Media, a film and TV drama series production house. It is also involved in the self-operated channels business. In addition, the company collaborates with third-party partners for distribution and development of IP content, as well as offers online paid reading and content adaptations. Further, it provides reading, copyright commercialization, and writer cultivation and brokerage services; and operates text work reading and related open platform through technology methods and digital media, including personal computers, Internet, and mobile network. Additionally, the company engages in the production and distribution of television series, web series, and films; licensing and distribution of film and television properties; licensing copyrights; sale of physical books; and operation of in-house online games, etc. The company was founded in 2002 and is headquartered in Shanghai, the People's Republic of China. China Literature Limited is a subsidiary of Tencent Holdings Limited.Read More CHLLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHLLF Stock News HeadlinesMay 1, 2024 | americanbankingnews.comChina Literature Limited (OTCMKTS:CHLLF) Sees Significant Growth in Short InterestMarch 18, 2024 | prnewswire.comChina Literature Announces 2023 Annual ResultsMay 9, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.February 29, 2024 | prnewswire.comChina Literature to Report Full Year 2023 Financial Results on March 18, 2024October 25, 2022 | msn.comClassical Chinese literature is having a moment. Can it boost soft power?October 6, 2022 | investing.comChina Literature Ltd (0772)September 29, 2022 | msn.comTencent’s China Literature ends Kindle-like e-reader service as Big Tech firms pull back on unprofitable businessesAugust 18, 2022 | msn.comEnglish literature drops out of top 10 most popular A-levels for first timeMay 9, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.August 15, 2022 | finance.yahoo.comChina Literature Announces 2022 Interim ResultsAugust 12, 2022 | finance.yahoo.comThe Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex PharmaceuticalsAugust 4, 2022 | finance.yahoo.comAmgen Narrows Sales Outlook Following Plans To Acquire ChemoCentryxAugust 4, 2022 | finance.yahoo.comUPDATE 2-Amgen adds potential blockbuster drug with $3.7 bln ChemoCentryx dealAugust 4, 2022 | ca.finance.yahoo.comAmgen adds potential blockbuster drug with $3.7 billion ChemoCentryx dealAugust 4, 2022 | finance.yahoo.comAmgen Plans $3.7 Billion ChemoCentryx Buyout, Tapping Into A New MarketAugust 3, 2022 | finance.yahoo.comChina Literature to Report First Half 2022 Financial Results on August 15, 2022July 14, 2022 | finance.yahoo.comChemoCentryx Stock Shows Market Leadership With Jump To 81 RS RatingJuly 8, 2022 | msn.comOn top of censorship, Chinese writers now have to contend with attacks from patriotic trolls, and that’s worryingSee More Headlines Receive CHLLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Literature and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorCommunication Services Industry Internet Content & Information Sub-IndustryN/A Current SymbolOTCMKTS:CHLLF CUSIPN/A CIKN/A Webir.yuewen.com PhoneN/AFaxN/AEmployees1,700Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Xiaonan Hou (Age 44)CEO, President & Executive Director Comp: $182.21kMr. William SunVice President of FinanceMr. Jincheng ZhaoGeneral Manager of InvestmentMs. Maggie ZhouHead of Capital Markets & Investor RelationsMr. Rong Zhang (Age 46)Senior Vice President Mr. Yan Huang (Age 40)VP & Executive Director Ms. Lan XuJoint Company SecretaryMr. Wai Keung Au ACA (Age 52)CPA, Joint Company Secretary More ExecutivesKey CompetitorsAdevinta ASAOTCMKTS:ADEVFBBTVOTCMKTS:BBTVFBoatimOTC:BTIMBuzzFeedNASDAQ:BZFDWCAR GroupOTCMKTS:CSXXYView All Competitors CHLLF Stock Analysis - Frequently Asked Questions How have CHLLF shares performed in 2024? China Literature's stock was trading at $3.2945 on January 1st, 2024. Since then, CHLLF stock has decreased by 1.5% and is now trading at $3.2450. View the best growth stocks for 2024 here. Are investors shorting China Literature? China Literature saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,311,300 shares, an increase of 5.6% from the March 31st total of 2,188,500 shares. Based on an average daily volume of 1,000 shares, the days-to-cover ratio is currently 2,311.3 days. View China Literature's Short Interest. How do I buy shares of China Literature? Shares of CHLLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CHLLF) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Literature Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.